Hyliion Holdings Reports Fourth-Quarter and Full-Year 2022 Financial Results
Hyliion Holdings Corp. (NYSE: HYLN) reported its fourth-quarter and full-year 2022 financial results, achieving key milestones for its Hypertruck ERX™ powertrain. The company secured a 10-unit order from DSV Logistics and announced a collaboration with Hyzon Motors for a fuel cell powered truck. Hyliion met its 2022 revenue guidance, ending the year with $422 million in available capital. The fourth-quarter revenue was $1.1 million, with operating expenses at $31.6 million. For 2023, operating expenses are guided between $130 to $140 million.
- Achieved new commercialization milestone for Hypertruck ERX.
- Secured 10-unit order from DSV Logistics and potential for 10 more.
- Collaboration with Hyzon Motors for fuel cell vehicle development.
- Met 2022 revenue guidance and ended with $422 million in capital.
- Net loss of $153.4 million for full-year 2022, a significant increase from previous year's loss.
Key Business Highlights
- Achieved new Hypertruck ERX™ commercialization milestone
-
Obtained a 10-unit order for the Hypertruck ERX powertrain from
DSV Logistics - Announcing collaboration with Hyzon Motors to jointly develop a fuel cell powered truck
- Met 2022 revenue guidance
-
Ended 2022 with
of available capital on the balance sheet$422 million -
2023 operating expense guidance of
-$130 $140 million
Executive Commentary
“We remained on track by hitting all our commercialization milestones for the Hypertruck ERX powertrain in 2022. The year was marked by many impactful accomplishments for
In the fourth quarter, the Company continued the design-verification phase of its Hypertruck ERX system with additional controlled fleet trials, most recently with Ruan Transportation. The Company also launched winter testing.
Overall,
Hypertruck ERX System Orders
During the fourth quarter the Company received 10 Hypertruck ERX system orders from
Hyzon Motors Collaboration
The Company is announcing a new agreement with Hyzon Motors to develop a fuel cell powered vehicle. This development is the third step in the Company’s multi-stage product roadmap towards a hydrogen future. The vehicle will use Hyliion’s electric powertrain system and Hyzon’s fuel cell technology as the generator. The powertrain will be integrated into a
“Today, we are announcing an innovative collaboration with Hyzon Motors to jointly develop a fuel cell powered vehicle. Hyzon is an industry leader in developing and manufacturing fuel cells purpose-built for heavy-duty applications, and
Financial Highlights, Operating Expense and 2023 Guidance
In the fourth quarter, the Company recorded
For full-year 2022, Hyliion’s net loss totaled
Looking forward, the Company expects full-year 2023 operating expenses to be in the
Fourth Quarter 2022 Conference Call
Conference Call Online Registration:
https://conferencingportals.com/event/vjUOPPlo
Access the Webcast:
https://events.q4inc.com/attendee/357822431
Full-year 2022 financial results for
About
Hyliion’s mission is to reduce the carbon intensity and greenhouse gas (GHG) emissions of Class 8 semi-trucks by being a leading provider of electrified powertrain solutions.
Forward Looking Statements
The information in this press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of present or historical fact included in this press release, regarding
CONSOLIDATED STATEMENTS OF OPERATIONS (Dollar amounts in thousands, except share and per share data) |
|||||||||||||||
|
Three Months Ended |
|
Year Ended |
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
|
(Unaudited) |
|
|
|
|
||||||||||
Revenues |
|
|
|
|
|
|
|
||||||||
Product sales and other |
$ |
1,095 |
|
|
$ |
200 |
|
|
$ |
2,106 |
|
|
$ |
200 |
|
Total revenues |
|
1,095 |
|
|
|
200 |
|
|
|
2,106 |
|
|
|
200 |
|
Cost of revenues |
|
|
|
|
|
|
|
||||||||
Product sales and other |
|
1,618 |
|
|
|
2,737 |
|
|
|
8,778 |
|
|
|
2,737 |
|
Total cost of revenues |
|
1,618 |
|
|
|
2,737 |
|
|
|
8,778 |
|
|
|
2,737 |
|
Gross loss |
|
(523 |
) |
|
|
(2,537 |
) |
|
|
(6,672 |
) |
|
|
(2,537 |
) |
Operating expenses |
|
|
|
|
|
|
|
||||||||
Research and development |
|
21,827 |
|
|
|
17,390 |
|
|
|
110,370 |
|
|
|
58,261 |
|
Selling, general and administrative |
|
9,733 |
|
|
|
9,188 |
|
|
|
41,988 |
|
|
|
35,299 |
|
Total operating expenses |
|
31,560 |
|
|
|
26,578 |
|
|
|
152,358 |
|
|
|
93,560 |
|
Loss from operations |
|
(32,083 |
) |
|
|
(29,115 |
) |
|
|
(159,030 |
) |
|
|
(96,097 |
) |
Interest income |
|
2,658 |
|
|
|
218 |
|
|
|
5,724 |
|
|
|
779 |
|
Gain (loss) on impairment and disposal of assets |
|
70 |
|
|
|
(730 |
) |
|
|
(19 |
) |
|
|
(730 |
) |
Other expense, net |
|
(32 |
) |
|
|
— |
|
|
|
(32 |
) |
|
|
— |
|
Net loss |
$ |
(29,387 |
) |
|
$ |
(29,627 |
) |
|
$ |
(153,357 |
) |
|
$ |
(96,048 |
) |
|
|
|
|
|
|
|
|
||||||||
Net loss per share, basic and diluted |
$ |
(0.16 |
) |
|
$ |
(0.17 |
) |
|
$ |
(0.87 |
) |
|
$ |
(0.56 |
) |
|
|
|
|
|
|
|
|
||||||||
Weighted-average shares outstanding, basic and diluted |
|
179,719,018 |
|
|
|
173,325,727 |
|
|
|
175,400,486 |
|
|
|
172,216,477 |
|
CONSOLIDATED BALANCE SHEETS (Dollar amounts in thousands, except share data) |
|||||
|
|
||||
|
|
2022 |
|
|
2021 |
Assets |
|
|
|
||
Current assets |
|
|
|
||
Cash and cash equivalents |
$ |
119,468 |
|
$ |
258,445 |
Accounts receivable, net |
|
1,136 |
|
|
70 |
Inventory |
|
74 |
|
|
114 |
Prepaid expenses and other current assets |
|
9,795 |
|
|
9,068 |
Short-term investments |
|
193,740 |
|
|
118,787 |
Total current assets |
|
324,213 |
|
|
386,484 |
|
|
|
|
||
Property and equipment, net |
|
5,606 |
|
|
2,235 |
Operating lease right-of-use assets |
|
6,470 |
|
|
7,734 |
Intangible assets, net |
|
200 |
|
|
235 |
Other assets |
|
1,686 |
|
|
1,535 |
Long-term investments |
|
108,568 |
|
|
180,217 |
Total assets |
$ |
446,743 |
|
$ |
578,440 |
|
|
|
|
||
Liabilities and stockholders’ equity |
|
|
|
||
Current liabilities |
|
|
|
||
Accounts payable |
$ |
2,800 |
|
$ |
7,455 |
Current portion of operating lease liabilities |
|
347 |
|
|
21 |
Accrued expenses and other current liabilities |
|
11,535 |
|
|
7,759 |
Total current liabilities |
|
14,682 |
|
|
15,235 |
|
|
|
|
||
Operating lease liabilities, net of current portion |
|
6,972 |
|
|
8,623 |
Other liabilities |
|
1,515 |
|
|
667 |
Total liabilities |
|
23,169 |
|
|
24,525 |
|
|
|
|
||
Commitments and contingencies |
|
|
|
||
|
|
|
|
||
Stockholders’ equity |
|
|
|
||
Common stock, |
|
18 |
|
|
17 |
Additional paid-in capital |
|
397,810 |
|
|
374,795 |
Retained earnings |
|
25,746 |
|
|
179,103 |
Total stockholders’ equity |
|
423,574 |
|
|
553,915 |
Total liabilities and stockholders’ equity |
$ |
446,743 |
|
$ |
578,440 |
CONSOLIDATED STATEMENTS OF CASH FLOWS (Dollar amounts in thousands) |
|||||||||||
|
Year Ended |
||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2020 |
|
Cash Flows from Operating Activities |
|
|
|
|
|
||||||
Net (loss) income |
$ |
(153,357 |
) |
|
$ |
(96,048 |
) |
|
$ |
324,117 |
|
Adjustments to reconcile net (loss) income to net cash used in operating activities: |
|
|
|
|
|
||||||
Depreciation and amortization |
|
1,227 |
|
|
|
884 |
|
|
|
850 |
|
Amortization of investment premiums and discounts |
|
1,250 |
|
|
|
1,816 |
|
|
|
— |
|
Loss on extinguishment of debt |
|
— |
|
|
|
— |
|
|
|
10,170 |
|
Noncash lease expense |
|
1,244 |
|
|
|
731 |
|
|
|
928 |
|
Inventory write-down |
|
5,641 |
|
|
|
2,298 |
|
|
|
— |
|
Loss on impairment and disposal of assets |
|
19 |
|
|
|
730 |
|
|
|
— |
|
Paid-in-kind interest on convertible notes payable |
|
— |
|
|
|
— |
|
|
|
1,085 |
|
Amortization of debt discount |
|
— |
|
|
|
— |
|
|
|
4,237 |
|
Share-based compensation |
|
6,979 |
|
|
|
4,922 |
|
|
|
294 |
|
Provision for doubtful accounts |
|
114 |
|
|
|
— |
|
|
|
— |
|
Change in fair value of convertible notes payable derivative liabilities |
|
— |
|
|
|
— |
|
|
|
1,358 |
|
Change in fair value of warrant liability |
|
— |
|
|
|
— |
|
|
|
(363,299 |
) |
Acquired in-process research and development |
|
28,752 |
|
|
|
— |
|
|
|
— |
|
Change in operating assets and liabilities, net of effects of business acquisition: |
|
|
|
|
|
||||||
Accounts receivable |
|
(1,180 |
) |
|
|
22 |
|
|
|
53 |
|
Inventory |
|
(5,601 |
) |
|
|
(2,280 |
) |
|
|
(132 |
) |
Prepaid expenses and other assets |
|
(571 |
) |
|
|
(475 |
) |
|
|
(8,150 |
) |
Accounts payable |
|
(4,660 |
) |
|
|
5,319 |
|
|
|
734 |
|
Accrued expenses and other liabilities |
|
4,571 |
|
|
|
2,155 |
|
|
|
5,764 |
|
Operating lease liabilities |
|
(1,305 |
) |
|
|
(576 |
) |
|
|
(953 |
) |
Net cash used in operating activities |
|
(116,877 |
) |
|
|
(80,502 |
) |
|
|
(22,944 |
) |
|
|
|
|
|
|
||||||
Cash Flows from Investing Activities |
|
|
|
|
|
||||||
Purchase of property and equipment and other |
|
(2,885 |
) |
|
|
(2,380 |
) |
|
|
(311 |
) |
Proceeds from sale of property and equipment |
|
152 |
|
|
|
45 |
|
|
|
22 |
|
Purchase of in-process research and development |
|
(14,428 |
) |
|
|
— |
|
|
|
— |
|
Payments for security deposit, net |
|
— |
|
|
|
(29 |
) |
|
|
— |
|
Purchase of investments |
|
(268,584 |
) |
|
|
(317,807 |
) |
|
|
(237,851 |
) |
Proceeds from sale and maturity of investments |
|
263,723 |
|
|
|
254,180 |
|
|
|
— |
|
Net cash used in investing activities |
|
(22,022 |
) |
|
|
(65,991 |
) |
|
|
(238,140 |
) |
|
|
|
|
|
|
||||||
Cash Flows from Financing Activities |
|
|
|
|
|
||||||
Business Combination and PIPE financing, net of issuance costs paid |
|
— |
|
|
|
— |
|
|
|
516,454 |
|
Proceeds from exercise of stock warrants, net of issuance costs |
|
— |
|
|
|
16,257 |
|
|
|
124,536 |
|
Proceeds from convertible notes payable issuance and derivative liabilities |
|
— |
|
|
|
— |
|
|
|
3,200 |
|
(Payments for)/proceeds from Paycheck Protection Program loan |
|
— |
|
|
|
(908 |
) |
|
|
908 |
|
Payments for deferred financing costs |
|
— |
|
|
|
— |
|
|
|
(468 |
) |
Repayments on finance lease obligations |
|
— |
|
|
|
(42 |
) |
|
|
(247 |
) |
Proceeds from exercise of common stock options |
|
79 |
|
|
|
591 |
|
|
|
121 |
|
Taxes paid related to net share settlement of equity awards |
|
(157 |
) |
|
|
— |
|
|
|
— |
|
Net cash (used in) provided by financing activities |
|
(78 |
) |
|
|
15,898 |
|
|
|
644,504 |
|
|
|
|
|
|
|
||||||
Net (decrease) increase in cash and cash equivalents and restricted cash |
|
(138,977 |
) |
|
|
(130,595 |
) |
|
|
383,420 |
|
Cash and cash equivalents and restricted cash, beginning of period |
|
259,110 |
|
|
|
389,705 |
|
|
|
6,285 |
|
Cash and cash equivalents and restricted cash, end of period |
$ |
120,133 |
|
|
$ |
259,110 |
|
|
$ |
389,705 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20230228006208/en/
press@hyliion.com
(833) 495-4466
ir@hyliion.com
(737) 292-8649
Source:
FAQ
What were Hyliion's fourth-quarter 2022 revenues?
What is Hyliion's 2023 operating expense guidance?
How many units did Hyliion secure orders for with DSV Logistics?
What was Hyliion's net loss for full-year 2022?